SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-023262
Filing Date
2024-06-10
Accepted
2024-06-10 06:12:20
Documents
14
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 440463
2 formpre14a_001.jpg GRAPHIC 1461
3 formpre14a_002.jpg GRAPHIC 1599
4 formpre14a_003.jpg GRAPHIC 1479
5 formpre14a_004.jpg GRAPHIC 1083
6 formpre14a_005.jpg GRAPHIC 1075
7 formpre14a_006.jpg GRAPHIC 1069
8 formpre14a_007.jpg GRAPHIC 939
9 formpre14a_008.jpg GRAPHIC 920
10 formpre14a_009.jpg GRAPHIC 5437
11 formpre14a_010.jpg GRAPHIC 4434
12 formpre14a_011.jpg GRAPHIC 1639
13 proxy_001.jpg GRAPHIC 1732057
14 proxy_002.jpg GRAPHIC 1444955
  Complete submission text file 0001493152-24-023262.txt   4847046
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41488 | Film No.: 241031412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)